Estimating UK cost-effectiveness thresholds associated with prescribing higher doses of buprenorphine and buprenorphine-naloxone to increase retention in opioid dependence treatment
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1267
https://www.valueinhealthjournal.com/article/S1098-3015(14)01318-7/fulltext
Title :
Estimating UK cost-effectiveness thresholds associated with prescribing higher doses of buprenorphine and buprenorphine-naloxone to increase retention in opioid dependence treatment
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01318-7&doi=10.1016/j.jval.2014.03.1267
First page :
A217
Section Title :
Mental Health
Open access? :
No
Section Order :
735